Molecular mimicry in multiple sclerosis

Mireia Sospedra1, Roland Martin

  • 1Unitat de Neuroimmunologia Clinica, Hospital Universitari Vall d'Hebron, Pg. Vall d'Hebron, 119-129, Barcelona, 08035, Spain.

Autoimmunity
|February 4, 2006
PubMed

Insights

Infectious agents and genetic factors contribute to autoimmune diseases like multiple sclerosis (MS). Molecular mimicry, where infections trigger autoimmune responses, is a key area of research.

Area of Science:

  • Immunology
  • Neuroscience
  • Infectious Diseases

Background:

  • Autoimmune diseases, such as multiple sclerosis (MS), arise from complex interactions between genetic predisposition and environmental factors.
  • Infectious agents are significant environmental triggers, with viral infections frequently preceding MS exacerbations or onset.

Purpose of the Study:

  • To explore the role of molecular mimicry in the development of autoimmune diseases following infections or vaccinations.
  • To review the evolution of the molecular mimicry concept and address unresolved questions.

Main Methods:

  • Review of epidemiological studies and scientific literature on infectious agents and autoimmune diseases.
  • Analysis of the molecular mimicry hypothesis, focusing on antigenic similarity between microbial and self-proteins.

Main Results:

  • Epidemiological data strongly suggest a link between viral infections and MS onset or exacerbations.
  • Molecular mimicry, a mechanism involving cross-reactivity between pathogen and self-antigens, is a prominent hypothesis for infection-induced autoimmunity.

Conclusions:

  • Molecular mimicry offers a plausible explanation for how infections can initiate or exacerbate autoimmune conditions like MS.
  • Despite advancements, further research is needed to fully elucidate the mechanisms and implications of molecular mimicry in human autoimmune diseases.